Board of Directors
Liang Lin Executive Chairman, Director
Liang Lin is the founder and CEO of Sol-Millennium Medical Group, dedicated to transforming the medical device sector. He launched the Sol-Millennium Medical project in Shanghai, driven by a commitment to a healthier future. His focus on innovation and patient safety has led to the development of advanced medical devices. Under his leadership, the company expanded into North America and Brazil through acquisitions of Inviro Medical Inc. and Medica Brazil, and established an EMEA office in Poland to address healthcare needs in Europe and the Middle East. Liang’s expertise and dedication have positioned Sol-Millennium as a leader in the industry.
Richard Buzbuzian President, Director
Richard Buzbuzian is a capital markets executive with over 25 years of investment experience in Canada and Europe. Most recently, Mr. Buzbuzian was president and a director of Drone Delivery Canada (TSXV: FLT), which he cofounded, took public, and raised over $120M Canadian in equity financings, achieving market capitalization in excess of $550M. Mr. Buzbuzian holds a degree from the University of Toronto.
Dr. John Leombruno Director
John Lemobruno has executive level experience in many areas of the pharmaceutical industry, including market access, medical information, pharmacovigilance, medical affairs, and business development. He co-founded Patient Direct (a patient support and specialty pharmacy provider) and GMD Distribution (a pharmaceutical distribution, patient support and specialty pharmacy services firm), both of which were acquired by McKesson Canada between 2010 and 2017. In 2019, John started OkRx, a Canadian Healthcare software company focusing on helping patients, prescribers, insurers, and pharmaceutical companies manage specialty medications. Dr. Leombruno is formally trained as a Pharmacist and has earned an MBA from Queen’s University and a PhD in Pharmacoepidemiology from University of Toronto.
Karen Dunlap Director
Karen Dunlap was President/COO, The Americas, UK, Europe and Board Director at Sol-Millennium Medical Group, from September 2011 – December 2019, responsible for acquisition of devices in order to launch into the US and overseeing markets to develop a strategic platform and establish a global sales/marketing team. She was a Sr. Vice President Business Development from March 2005 - September 2011 for Inviro Medical, and represented the company in many different roles and regions including Target Accounts US, Canada and Latin America. Prior to working with Inviro Medical, Ms. Dunlap was an independent consultant working with start-up emerging companies on product development and launch. Ms. Dunlap was Vice President Sales for NMT, partnering with Pharmaceutical Companies on specific medication delivery, and Regional Manager for Medfusion and Medex, focused in the Neonatal and Pediatric markets, where she has extensive experience in accurate medication delivery systems.
Philip Cortese Director
Mr. Cortese is a seasoned banker with over 30 years of experience in the financial institution industry and has held senior managerial positions at RBC, TD Bank and CIBC for over half of those years. In 2002, he was recruited by TD Bank to head the Quebec office of its real estate financing commercial mortgage-backed securities (CMBS) origination group as vice-president for the Quebec region. The CMBS group originated close to $1 billion of new commercial mortgages over a period of just 4 years. In October of 2012, he joined a local real estate investor, Kheng Ly, and together branded the development company now known as Brivia Group. Mr. Cortese is a former Canadian Securities Institute graduate and a licensed commercial real estate broker.
Kwun Loy Liu Director
Kwun Loy Liu has over 18 years of work experience in healthcare, investment and strategic consulting across Asia, Europe and North America. He is currently the Investment Vice President at Winner Medical and leading the strategic investment effort of the group. Prior to joining Winner Medical, Mr. Liu worked at McKinsey, Morgan Stanley, Bain Capital and Shenzhen Neptunus Group. Mr. Liu is a member of the Board of Directors of Sol Millennium and holds degrees in business administration and software engineering from The University of Hong Kong.